Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.
- Published In:
- The Journal of pediatrics, 181, 146-153.e3 (2017)
- Authors:
- Danne, Thomas, Biester, Torben, Kapitzke, Kerstin, Jacobsen, Sanja H, Jacobsen, Lisbeth V, Petri, Kristin C Carlsson, Hale, Paula M, Kordonouri, Olga
- Database ID:
- RPEP-03259
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03259APA
Danne, Thomas; Biester, Torben; Kapitzke, Kerstin; Jacobsen, Sanja H; Jacobsen, Lisbeth V; Petri, Kristin C Carlsson; Hale, Paula M; Kordonouri, Olga. (2017). Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.. The Journal of pediatrics, 181, 146-153.e3. https://doi.org/10.1016/j.jpeds.2016.10.076
MLA
Danne, Thomas, et al. "Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.." The Journal of pediatrics, 2017. https://doi.org/10.1016/j.jpeds.2016.10.076
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide in an Adolescent Population with Obesity: A Rand..." RPEP-03259. Retrieved from https://rethinkpeptides.com/research/danne-2017-liraglutide-in-an-adolescent
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.